Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PIMAVANSERIN Cause Transient ischaemic attack? 75 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 75 reports of Transient ischaemic attack have been filed in association with PIMAVANSERIN (pimavanserin). This represents 0.2% of all adverse event reports for PIMAVANSERIN.

75
Reports of Transient ischaemic attack with PIMAVANSERIN
0.2%
of all PIMAVANSERIN reports
17
Deaths
51
Hospitalizations

How Dangerous Is Transient ischaemic attack From PIMAVANSERIN?

Of the 75 reports, 17 (22.7%) resulted in death, 51 (68.0%) required hospitalization, and 2 (2.7%) were considered life-threatening.

Is Transient ischaemic attack Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PIMAVANSERIN. However, 75 reports have been filed with the FAERS database.

What Other Side Effects Does PIMAVANSERIN Cause?

Hallucination (10,839) Death (9,352) Drug ineffective (5,545) Product dose omission issue (3,808) Confusional state (3,779) Fall (3,366) Delusion (2,421) Hallucination, visual (1,954) Gait disturbance (1,923) Parkinson's disease (1,918)

What Other Drugs Cause Transient ischaemic attack?

APIXABAN (1,157) RIVAROXABAN (820) LENALIDOMIDE (655) ADALIMUMAB (604) ASPIRIN (587) ROSIGLITAZONE (585) NAPROXEN (521) LEVOTHYROXINE (517) DABIGATRAN ETEXILATE (471) CLOPIDOGREL BISULFATE (454)

Which PIMAVANSERIN Alternatives Have Lower Transient ischaemic attack Risk?

PIMAVANSERIN vs PIMECROLIMUS PIMAVANSERIN vs PIMOZIDE PIMAVANSERIN vs PINAVERIUM PIMAVANSERIN vs PINDOLOL PIMAVANSERIN vs PIOGLITAZONE

Related Pages

PIMAVANSERIN Full Profile All Transient ischaemic attack Reports All Drugs Causing Transient ischaemic attack PIMAVANSERIN Demographics